Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BIMSA, accelerating long sequence alignment using processing-in-memory

  • Alonso-Marín, Alejandro
  • Fernandez, Ivan
  • Aguado-Puig, Quim|||0000-0003-4871-3192
  • Gómez-Luna, Juan|||0000-0002-6514-1571
  • Marco-Sola, Santiago|||0000-0001-7951-3914
  • Mutlu, Onur
  • Moreto, Miquel|||0000-0002-9848-8758
Recent advances in sequencing technologies have stressed the critical role of sequence analysis algorithms and tools in genomics and healthcare research. In particular, sequence alignment is a fundamental building block in many sequence analysis pipelines and is frequently a performance bottleneck both in terms of execution time and memory usage. Classical sequence alignment algorithms are based on dynamic programming and often require quadratic time and memory with respect to the sequence length. As a result, classical sequence alignment algorithms fail to scale with increasing sequence lengths and quickly become memory-bound due to data-movement penalties. Processing-In-Memory (PIM) is an emerging architectural paradigm that seeks to accelerate memory-bound algorithms by bringing computation closer to the data to mitigate data-movement penalties. This work presents BIMSA (idirectional n-emory equence lignment), a PIM design and implementation for the state-of-the-art sequence alignment algorithm BiWFA (Bidirectional Wavefront Alignment), incorporating new hardware-aware optimizations for a production-ready PIM architecture (UPMEM). BIMSA supports aligning sequences up to 100K bases, exceeding the limitations of state-of-the-art PIM implementations. First, BIMSA achieves speedups up to 22.24× (11.95× on average) compared to state-of-the-art PIM-enabled implementations of sequence alignment algorithms. Second, achieves speedups up to 5.84× (2.83× on average) compared to the highest-performance multicore CPU implementation of BiWFA. Third, BIMSA exhibits linear scalability with the number of compute units in memory, enabling further performance improvements with upcoming PIM architectures equipped with more compute units and achieving speedups up to 9.56× (4.7× on average).
Repisalud
Publication Artículo científico (JournalArticle)

Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain

  • Ardanuy, Carmen
  • de la Campa, Adela G
  • García, Ernesto
  • Fenoll, Asuncion
  • Calatayud, Laura
  • Cercenado, Emilia
  • Pérez-Trallero, Emilio
  • Bouza, Emilio
  • Liñares, Josefina
Since 2004, a total of 131 isolates of Streptococcus pneumoniae multidrug-resistant invasive serotype 8 have been detected in Spain. These isolates showed resistance to erythromycin, clindamycin, tetracycline, and ciprofloxacin. All isolates were obtained from adult patients and shared a common genotype (sequence type [ST]63; penicillin-binding protein 1a [pbp1a], pbp2b, and pbp2x gene profiles; ermB and tetM genes; and a ParC-S79F change). Sixty-eight isolates that required a ciprofloxacin MIC ≥16 μg/mL had additional gyrA gene changes. Serotype 8-ST63 pbp2x sequences were identical with those of antimicrobial drug-susceptible serotype 8-ST53 isolates. Serotype 8-ST63 pbp2b sequences were identical with those of the multidrug-resistant Sweden 15A-ST63 clone. Recombination between the capsular locus and flanking regions of an ST53 isolate (donor) and an ST63 pneumococcus (recipient) generated the novel 15A-ST63 clone. One recombination point was upstream of pbp2x and another was within pbp1a. A serotype 8-ST63 clone was identified as a cause of invasive disease in Spain.
Repisalud
Publication Artículo científico (JournalArticle)

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

  • Vázquez-Sánchez, Sara
  • Blasco, Ana
  • Polo-Salguero, Marina
  • Mourino-Álvarez, Laura
  • Gil-Fernández, Marta
  • Corbacho-Alonso, Nerea
  • Navarro-García, José Alberto
  • Mercado-García, Elisa
  • González-Lafuente, Laura
  • Rodríguez-Sánchez, Elena
  • González-Moreno, Daniel
  • Pérez-Gómez, Alberto
  • Matutano, Andrea
  • Vázquez, Jesús
  • López, Juan Antonio
  • Fernández-Velasco, María
  • Barderas, María G
  • Ruiz-Hurtado, Gema
Elevation of FGF23 (fibroblast growth factor 23) and decreased Klotho levels have been associated with various cardiovascular and renal diseases. However, the combined study of the FGF23-Klotho axis in ischemic heart disease remains elusive. We analyzed the associations between circulating FGF23 and Klotho levels with cardiac and renal parameters, as well as mortality outcomes following myocardial infarction (MI). Cardiac tissue from patients with ischemic heart disease and a post-MI mouse model were analyzed to assess myocardial FGF23 expression. Proteomic analysis was performed to examine myocardial pathways activated by FGF23 and regulated by Klotho. We observed an inverse correlation between circulating levels of FGF23 and Klotho in patients after MI. Elevated plasma FGF23 levels were particularly associated with ST-segment-elevation MI and cardiac dysfunction, including reduced left ventricular ejection fraction, prolonged corrected interval, and higher Killip-Kimball classification of cardiac risk, identifying FGF23 as a potential prognostic marker of overall and cardiac-related mortality. In contrast, systemic Klotho levels were reduced in patients with ST-segment-elevation MI but did not correlate with mortality. In cardiac tissue, ischemic injury significantly upregulated FGF23 expression. Although Klotho prevented FGF23-induced proteomic alterations, it did not inhibit cardiac FGF23 overexpression in the post-MI model. FGF23 represents a promising biomarker for mortality and cardiac dysfunction in patients with MI. Although Klotho does not appear to be a reliable predictor of mortality after MI, its cardioprotective properties suggest a role in modulating FGF23-driven metabolic, structural, and proliferative processes in the myocardium.
Repisalud
Publication Artículo científico (JournalArticle)

A Novel Typing Method for Streptococcus pneumoniae Using Selected Surface Proteins

  • Domenech, Arnau
  • Moreno, Javier
  • Ardanuy, Carmen
  • Liñares, Josefina
  • de la Campa, Adela G
  • Martin-Galiano, Antonio Javier
The diverse pneumococcal diseases are associated with different pneumococcal lineages, or clonal complexes. Nevertheless, intra-clonal genomic variability, which influences pathogenicity, has been reported for surface virulence factors. These factors constitute the communication interface between the pathogen and its host and their corresponding genes are subjected to strong selective pressures affecting functionality and immunogenicity. First, the presence and allelic dispersion of 97 outer protein families were screened in 19 complete pneumococcal genomes. Seventeen families were deemed variable and were then examined in 216 draft genomes. This procedure allowed the generation of binary vectors with 17 positions and the classification of strains into surfotypes. They represent the outer protein subsets with the highest inter-strain discriminative power. A total of 116 non-redundant surfotypes were identified. Those sharing a critical number of common protein features were hierarchically clustered into 18 surfogroups. Most clonal complexes with comparable epidemiological characteristics belonged to the same or similar surfogroups. However, the very large CC156 clonal complex was dispersed over several surfogroups. In order to establish a relationship between surfogroup and pathogenicity, the surfotypes of 95 clinical isolates with different serogroup/serotype combinations were analyzed. We found a significant correlation between surfogroup and type of pathogenic behavior (primary invasive, opportunistic invasive, and non-invasive). We conclude that the virulent behavior of S. pneumoniae is related to the activity of collections of, rather than individual, surface virulence factors. Since surfotypes evolve faster than MLSTs and directly reflect virulence potential, this novel typing protocol is appropriate for the identification of emerging clones.
Repisalud
Publication Artículo científico (JournalArticle)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

  • Càmara, Jordi
  • Marimón, José María
  • Cercenado, Emilia
  • Larrosa, Nieves
  • Quesada, María Dolores
  • Fontanals, Dionísia
  • Cubero, Meritxell
  • Pérez-Trallero, Emilio
  • Fenoll, Asuncion
  • Liñares, Josefina
  • Ardanuy, Carmen
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008-2009) and after (2012-2013). The 13-valent pneumococcal conjugate vaccine (PCV13) licensure was conducted in order to analyze the impact of PCV13 introduction for children on adult IPD. A total of 1558 IPD episodes were detected. The incidence of IPD decreased significantly in the second period by -33.9% (95% CI, -40.3% to -26.8%). IPD due to PCV7 serotypes (-52.7%; 95% CI, -64.2% to -37.5%) and to PCV13 additional serotypes (-55.0% 95% CI, -62.0% to -46.7%) significantly decreased whereas IPD due to non-PCV13 serotypes remained stable (1.0% 95% CI, -12.9% to 17.2%). IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95%CI -35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95%CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST3866C, and serotype 8 that decreased (-34.9%, 95%CI, -57.1 to -1.2, p = 0.049), related to a decline of the ST638. The recombinant clone ST652111A (variant of ST1569V) increased in frequency. The decrease of serotype 19A IPD was linked to a fall in those antibiotic susceptible clones. In the last period, rates of penicillin- and cefotaxime-resistance remained under 10% and 4%, respectively. Adult IPD decreased after the PCV13 introduction in Spain due to herd protection. The spread of multidrug resistant clones (ST3866C, ST652111A) related to non-PCV13 serotypes needs further surveillance.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Leveraging HLS to Design a Versatile &amp, High-Performance Classic McEliece Accelerator

  • Kostalabros, Ioannis-Vatistas
  • Ribes, Jordi
  • Carril, Xavier
  • Farràs, Oriol
  • Moreto, Miquel
  • Hernández Luz, Carles|||0000-0003-1192-6223
[EN] By harnessing fundamental quantum properties, a large-scale quantum computer could undermine currently deployed public-key algorithms. The post-quantum, code-based cryptosystem Classic McEliece (CM)addresses this security concern. However, its large public key size (up to 1.3 MB) poses various hardware implementation challenges. In this article, we focus on the high memory bandwidth requirements of the CM encoding function, in the context of heterogeneous CPU-FPGA devices. More concretely, we target the acceleration of public-key loading and processing from any globally shared or accelerator-private memory system. We present a novel and constant-time accelerator eEnc that exploits the elevated parallelization potential of FPGA devices to yield high-performance results. Our accelerator implements the encoding and the random error vector generation functions, which comprise the main computational load of Encapsulation. Two accelerator design variants are introduced, providing different hardware tradeoffs. Regarding intra-accelerator data communication, and unlike other state-of-the-art (SOTA) works, we combine a streaming protocol with task-level parallelization to remove the need to store the public key in accelerator-private memories. Our proposed design shows new record execution times over its SOTA counterparts, ranging on average from 3.5x up to 7.7x across the five security level parameter sets. Our end-to-end implementation in a Zynq SoC shows an average speedup of 2.2x compared to a 64-bit vectorized CM software-baseline. The elevated logic resource consumption, characteristic of HLS designs, can be readily adjusted with a performance tradeoff., This work has been partially supported by the European HiPEAC Network of Excellence, by the Spanish Ministry of Science and Innovation MCIN/AEI 10.13039/501100011033 (contracts ACITHEC PID2021-124928NB-I00, PID2019-107255GB-C21 and "Ramon y Cajal" fellowship No. RYC2020-030685-I) , by the Generalitat de Catalunya (contract 2021-SGR-00763, 2021-SGR-00115 and 2023-146511NB-I00) , by the Agency for Management of University and Research Grants (AGAUR) of the Government of Catalonia under "Ajuts per a la contractacio de personal investigador novell" (fellowships No. 2019FI B01274 and 2024 FI-1 00520) , by the European Union within the framework of the ERDF of Catalonia 2014-2020 under the DRAC project [001-P-001723] , and by the project HERMES funded by the European NextGenerationEU/PRTR via INCIBE.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism

  • Merino-Galán, Leyre
  • Zamarbide, Marta
  • Belloso-Iguerategui, Arantzazu
  • Alonso-Moreno, Marta C.
  • Gago, Belén
  • Reinares-Sebastián, Alejandro
  • Blesa, Javier
  • Dumitriu, Dani
  • Quiroga-Varela, Ana
  • Rodríguez-Oroz, María Cruz
Parkinson’s disease has a long premotor phase with ongoing dopaminergic degeneration, yet its compensatory mechanisms remain unclear. Using a rat model with A53T α-synuclein overexpression in the substantia nigra, we analyzed striatal synaptic changes at 72 h, 1, 2, and 4 weeks post-inoculation, before motor signs appeared. Dopamine concentration decreased from 72 h, and chemical long-term potentiation was simultaneously inhibited, partially recovering by 4 weeks. At this time point, dopaminergic degeneration and post-synaptic morphological and ultrastructural dendritic spine remodelling became significant. These changes included a reduction in thin dendritic spines, an increase in mushroom spine head volume, a decrease in smooth endoplasmic reticulum-containing spines, and an increase in dendritic branching. In conclusion, impaired striatal dopaminergic neurotransmisson diminishes striatal synaptic plasticity, which can be partially restored through complex structural changes in striatal spines. These adaptations might represent fundamental homeostatic mechanisms regulating synaptic function during the premotor stage of Parkinson’s disease. (Figure presented.), This study was funded by the Instituto de Salud Carlos III (ISCIII) through the projects PI14/00763 and PI19/01915, Co-funded by the European Regional Development fund ‘A way to make Europe’. LM-G held a Predoctoral Research Fellowship from the University of the Basque Country (UPV/EHU) and two travel grants from the UPV/EHU and Boehringer Ingelheim, respectively, to perform consecutive research stays at Columbia University. AB-I held a Predoctoral Research Fellowship from the Government of the Basque Country. J.B held a Miguel Servet Program CP19/00200 from Instituto de Salud Carlos III. J.B and A.R-S are funded by Aligning Science Across Parkinson’s [ASAP-020505] through the Michael J. Fox Foundation for Parkinson’s Research (MJFF).The authors would like to thank the CIMA-Universidad Navarra, University of the Basque Country (UPV/EHU), Columbia University, and Boehringer Ingelheim for their support and use of their infrastructures.
Docta Complutense
Publication Artículo científico (JournalArticle)

The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23

  • Navarro García, José Alberto
  • Salguero Bodes, Rafael
  • Praga Terente, Manuel
  • Arribas Ynsaurriaga, Fernando
  • Bueno Zamora, Héctor José
  • Ruilope Urioste, Luis Miguel
  • Ruiz Hurtado, Gema
Abstract Background: Chronic kidney disease (CKD) is associated with increased propensity for arrhythmias. In this context, ventricular repolarization alterations have been shown to predispose to fatal arrhythmias and sudden cardiac death. Between mineral bone disturbances in CKD patients, increased fibroblast growth factor (FGF) 23 and decreased Klotho are emerging as important effectors of cardiovascular disease. However, the relationship between imbalanced FGF23-Klotho axis and the development of cardiac arrhythmias in CKD remains unknown. Methods: We carried out a translational approach to study the relationship between the FGF23-Klotho signaling axis and acquired long QT syndrome in CKD-associated uremia. FGF23 levels and cardiac repolarization dynamics were analyzed in patients with dialysis-dependent CKD and in uremic mouse models of 5/6 nephrectomy (Nfx) and Klotho deficiency (hypomorphism), which show very high systemic FGF23 levels. Results: Patients in the top quartile of FGF23 levels had a higher occurrence of very long QT intervals (> 490 ms) than peers in the lowest quartile. Experimentally, FGF23 induced QT prolongation in healthy mice. Similarly, alterations in cardiac repolarization and QT prolongation were observed in Nfx mice and in Klotho hypomorphic mice. QT prolongation in Nfx mice was explained by a significant decrease in the fast transient outward potassium (K+) current (Itof), caused by the downregulation of K+ channel 4.2 subunit (Kv4.2) expression. Kv4.2 expression was also significantly reduced in ventricular cardiomyocytes exposed to FGF23. Enhancing Klotho availability prevented both long QT prolongation and reduced Itof current. Likewise, administration of recombinant Klotho blocked the downregulation of Kv4.2 expression in Nfx mice and in FGF23-exposed cardiomyocytes. Conclusion: The FGF23-Klotho axis emerges as a new therapeutic target to prevent acquired long QT syndrome in uremia by minimizing the predisposition to potentially fatal ventricular arrhythmias and sudden cardiac death in patients with CKD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Internal translation of the connexin 43 transcript

  • Salat-Canela, Clàudia
  • Sesé, Marta|||0000-0003-1473-4833
  • Peula, Cristina
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Aasen, Trond|||0000-0003-0763-2695
Connexin 43 (Cx43), the most widely expressed gap junction protein, is associated with a number of physiological and pathological conditions. Many functions of Cx43 have been shown to be independent of gap junction formation and only require the expression of Cx43 C-terminal fragments. Recent evidence demonstrated that naturally occurring C-terminal isoforms can be generated via internal translation. Here, we confirm that C-terminal domains of Cx43, particularly the major 20-kDa isoform, can be independently generated and regulated by internal translation of the same single GJA1 gene transcript that encodes full-length Cx43. Through direct RNA transfection experiments, we provide evidence that internal translation is not due to a bona fide cap-independent IRES-mediated mechanism, as upstream ribosomal scanning or translation is required. In addition to the mTOR pathway, we show for the first time, using both inhibitors and cells from knockout mice, that the Mnk1/2 pathway regulates the translation of the main 20-kDa isoform. Internal translation of the Cx43 transcript occurs but is not cap-independent and requires translation upstream of the internal start codon. In addition to the PI3K/AKT/mTOR pathway, the major 20-kDa isoform is regulated by the Mnk1/2 pathway. Our results have major implications for past and future studies escribing gap junction-independent functions of Cx43 in cancer and other pathological conditions. This study provides further clues to the signalling pathways that regulate internal mRNA translation, an emerging mechanism that allows for increased protein diversity and functional complexity from a single mRNA transcript.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

  • Castellana, Barbara
  • Aasen, Trond|||0000-0003-0763-2695
  • Moreno-Bueno, Gema
  • Dunn, Sandra E.
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Epithelial to mesenchymal transition (EMT) induces cell plasticity and promotes metastasis. The multifunctional oncoprotein Y-box binding protein-1 (YB-1) and the pleiotropic cytokine interleukin 6 (IL-6) have both been implicated in tumor cell metastasis and EMT, but via distinct pathways. Here, we show that direct interplay between YB-1 and IL-6 regulates breast cancer metastasis. Overexpression of YB-1 in breast cancer cell lines induced IL-6 production while stimulation with IL-6 increased YB-1 expression and YB-1 phosphorylation. Either approach was sufficient to induce EMT features, including increased cell migration and invasion. Silencing of YB-1 partially reverted the EMT and blocked the effect of IL-6 while inhibition of IL-6 signaling blocked the phenotype induced by YB-1 overexpression, demonstrating a clear YB-1/IL-6 interdependence. Our findings describe a novel signaling network in which YB-1 regulates IL-6, and vice versa, creating a positive feed-forward loop driving EMT-like metastatic features during breast cancer progression. Identification of signaling partners or pathways underlying this co-dependence may uncover novel therapeutic opportunities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo

  • Sesé, Marta|||0000-0003-1473-4833
  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Bejar Serrano, Eva|||0000-0002-1843-3010
  • McGrail, Kimberley|||0000-0001-7227-7306
  • Thomas, George|||0000-0002-1236-1714
  • Aasen, Trond|||0000-0003-0763-2695
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Breast cancer is the most prevalent malignancy in women and there is an urgent need for new therapeutic drugs targeting aggressive and metastatic subtypes, such as hormone-refractory triple-negative breast cancer (TNBC). Control of protein synthesis is vital to cell growth and tumour progression and permits increased resistance to therapy and cellular stress. Hypoxic cancer cells attain invasive and metastatic properties and chemotherapy resistance, but the regulation and role of protein synthesis in this setting is poorly understood. We performed a polysomal RNA-Seq screen in non-malignant breast epithelial (MCF10A) and TNBC (MDA-MB-231) cells exposed to normoxic or hypoxic conditions and/or treated with an mTOR pathway inhibitor. Analysis of both the transcriptome and the translatome identified mRNA transcripts translationally activated or repressed by hypoxia in an mTOR-dependent or -independent manner. Integrin beta 3 (ITGB3) was translationally activated in hypoxia and its knockdown increased apoptosis and reduced survival and migration, particularly under hypoxic conditions. Moreover, ITGB3 was required for sustained TGF-β pathway activation and for the induction of Snail and associated epithelial-mesenchymal transition markers. ITGB3 downregulation significantly reduced lung metastasis and improved overall survival in mice. Collectively, these data suggest that ITGB3 is translationally activated in hypoxia and regulates malignant features, including epithelial-mesenchymal transition and cell migration, through the TGF-β pathway, revealing a novel angle for the treatment of therapy-resistant hypoxic tumours.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

  • Càmara, Jordi|||0000-0002-0817-0931
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Quesada, Maria Dolores|||0000-0001-8360-3787
  • Fontanals, Dionísia|||0000-0002-2994-6065
  • Cubero, Meritxell
  • Pérez Trallero, Emilio
  • Fenoll, Asunción
  • Liñares, Josefina
  • Ardanuy, Carmen|||0000-0003-0225-607X
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008±2009) and after (2012±2013). The 13-valent pneumococcal conjugate vaccine (PCV13) licensure was conducted in order to analyze the impact of PCV13 introduction for children on adult IPD. A total of 1558 IPD episodes were detected. The incidence of IPD decreased significantly in the second period by -33.9% (95% CI, -40.3% to -26.8%). IPD due to PCV7 serotypes (-52.7%; 95% CI, -64.2% to -37.5%) and to PCV13 additional serotypes (-55.0% 95% CI, -62.0% to -46.7%) significantly decreased whereas IPD due to non-PCV13 serotypes remained stable (1.0% 95% CI, -12.9% to 17.2%). IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95%CI -35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95% CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST3866C, and serotype 8 that decreased (-34.9%, 95%CI, -57.1 to -1.2, p = 0.049), related to a decline of the ST638. The recombinant clone ST652111A (variant of ST1569V) increased in frequency. The decrease of serotype 19A IPD was linked to a fall in those antibiotic susceptible clones. In the last period, rates of penicillin- and cefotaxime-resistance remained under 10% and 4%, respectively. Adult IPD decreased after the PCV13 introduction in Spain due to herd protection. The spread of multidrug resistant clones (ST3866C, ST652111A) related to non-PCV13 serotypes needs further surveillance.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Insight into the role and regulation of gap junction genes in lung cancer and identification of nuclear Cx43 as a putative biomarker of poor prognosis

  • Aasen, Trond|||0000-0003-0763-2695
  • Sansano, Irene|||0000-0003-0188-5210
  • Montero, María Ángeles
  • Romagosa, Cleofé
  • Temprana-Salvador, Jordi|||0000-0001-9516-1680
  • Martinez-Marti, Alex|||0000-0002-6714-9526
  • Moliné, Teresa|||0000-0003-4912-5114
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Direct intercellular communication, mediated by gap junctions formed by the connexin transmembrane protein family, is frequently dysregulated in cancer. Connexins have been described as tumour suppressors, but emerging evidence suggests that they can also act as tumour promoters. This feature is connexin- and tissue-specific and may be mediated by complex signalling pathways through gap junctions or hemichannels or by completely junction-independent events. Lung cancer is the number one cancer in terms of mortality worldwide, and novel biomarkers and therapeutic targets are urgently needed. Our objective was to gain a better understanding of connexins in this setting. We used several in silico tools to analyse TCGA data in order to compare connexin mRNA expression between healthy lung tissue and lung tumours and correlated these results with gene methylation patterns. Using Kaplan-Meier plotter tools, we analysed a microarray dataset and an RNA-seq dataset of non-small cell lung tumours in order to correlate connexin expression with patient prognosis. We found that connexin mRNA expression is frequently either upregulated or downregulated in lung tumours. This correlated with both good and poor prognosis (overall survival) in a clear connexin isoform-dependent manner. These associations were strongly influenced by the histological subtype (adenocarcinoma versus squamous cell carcinoma). We present an overview of all connexins but particularly focus on four isoforms implicated in lung cancer: Cx26, Cx30.3, Cx32 and Cx43. We further analysed the protein expression and localization of Cx43 in a series of 73 human lung tumours. We identified a subset of tumours that exhibited a unique strong nuclear Cx43 expression pattern that predicted worse overall survival (p = 0.014). Upon sub-stratification, the prognostic value remained highly significant in the adenocarcinoma subtype (p = 0.002) but not in the squamous carcinoma subtype (p = 0.578). This finding highlights the importance of analysis of connexin expression at the protein level, particularly the subcellular localization. Elucidation of the underlying pathways regulating Cx43 localization may provide for novel therapeutic opportunities.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Bespoken Nanoceria, An Effective Treatment in Experimental Hepatocellular Carcinoma

  • Fernández-Varo, Guillermo|||0000-0002-7776-3300
  • Perramón, Meritxell|||0000-0002-1944-8337
  • Carvajal, Silvia
  • Oró, Denise
  • Casals, Eudald|||0000-0002-2900-7295
  • Boix, Loreto|||0000-0002-6015-3901
  • Oller, Laura
  • Macías-Muñoz, Laura
  • Marfà, Santi
  • Casals, Gregori|||0000-0002-3271-1371
  • Morales Ruiz, Manuel|||0000-0002-9074-2272
  • Casado, Pedro|||0000-0002-4207-9349
  • Rodríguez Cutillas, Pedro|||0000-0002-3426-2274
  • Bruix, Jordi|||0000-0002-9826-0753
  • Navasa, Miquel|||0000-0002-3130-9604
  • Fuster, Josep
  • García-Valdecasas, Juan Carlos
  • Pavel, Mihai C.
  • Puntes, Víctor|||0000-0001-8996-9499
  • Jiménez, Wladimiro|||0000-0002-9376-0214
Despite the availability of new-generation drugs, hepatocellular carcinoma (HCC) is still the third most frequent cause of cancer-related deaths worldwide. Cerium oxide nanoparticles (CeONPs) have emerged as an antioxidant agent in experimental liver disease because of their antioxidant, anti-inflammatory, and antisteatotic properties. In the present study, we aimed to elucidate the potential of CeONPs as therapeutic agents in HCC. HCC was induced in 110 Wistar rats by intraperitoneal administration of diethylnitrosamine for 16 weeks. Animals were treated with vehicle or CeONPs at weeks 16 and 17. At the eighteenth week, nanoceria biodistribution was assessed by mass spectrometry (MS). The effect of CeONPs on tumor progression and animal survival was investigated. Hepatic tissue MS-based phosphoproteomics as well as analysis of principal lipid components were performed. The intracellular uptake of CeONPs by human ex vivo perfused livers and human hepatocytes was analyzed. Nanoceria was mainly accumulated in the liver, where it reduced macrophage infiltration and inflammatory gene expression. Nanoceria treatment increased liver apoptotic activity, while proliferation was attenuated. Phosphoproteomic analysis revealed that CeONPs affected the phosphorylation of proteins mainly related to cell adhesion and RNA splicing. CeONPs decreased phosphatidylcholine-derived arachidonic acid and reverted the HCC-induced increase of linoleic acid in several lipid components. Furthermore, CeONPs reduced serum alpha-protein levels and improved the survival of HCC rats. Nanoceria uptake by ex vivo perfused human livers and in vitro human hepatocytes was also demonstrated. These data indicate that CeONPs partially revert the cellular mechanisms involved in tumor progression and significantly increase survival in HCC rats, suggesting that they could be effective in patients with HCC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Connexins, Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease

  • Aasen, Trond|||0000-0003-0763-2695
  • Johnstone, Scott|||0000-0003-1920-5033
  • Vidal-Brime, Laia
  • Lynn, K. Sabrina
  • Koval, Michael|||0000-0002-5422-5614
Connexins are tetraspan transmembrane proteins that form gap junctions and facilitate direct intercellular communication, a critical feature for the development, function, and homeostasis of tissues and organs. In addition, a growing number of gap junction-independent functions are being ascribed to these proteins. The connexin gene family is under extensive regulation at the transcriptional and post-transcriptional level, and undergoes numerous modifications at the protein level, including phosphorylation, which ultimately affects their trafficking, stability, and function. Here, we summarize these key regulatory events, with emphasis on how these affect connexin multifunctionality in health and disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis

  • Varela-Eirín, Marta
  • Varela-Vázquez, Adrián
  • Guitián-Caamaño, Amanda
  • Paíno, Carlos Luis
  • Mato, Virginia
  • Largo, Raquel|||0000-0001-6525-2944
  • Aasen, Trond|||0000-0003-0763-2695
  • Tabernero, Arantxa|||0000-0001-6302-6134
  • Fonseca, Eduardo|||0000-0002-8048-2681
  • Kandouz, Mustapha
  • Caeiro Rey, José Ramón
  • Blanco, Alfonso
  • Mayán, María D.
Osteoarthritis (OA), a chronic disease characterized by articular cartilage degeneration, is a leading cause of disability and pain worldwide. In OA, chondrocytes in cartilage undergo phenotypic changes and senescence, restricting cartilage regeneration and favouring disease progression. Similar to other wound-healing disorders, chondrocytes from OA patients show a chronic increase in the gap junction channel protein connexin43 (Cx43), which regulates signal transduction through the exchange of elements or recruitment/release of signalling factors. Although immature or stem-like cells are present in cartilage from OA patients, their origin and role in disease progression are unknown. In this study, we found that Cx43 acts as a positive regulator of chondrocyte-mesenchymal transition. Overactive Cx43 largely maintains the immature phenotype by increasing nuclear translocation of Twist-1 and tissue remodelling and proinflammatory agents, such as MMPs and IL-1β, which in turn cause cellular senescence through upregulation of p53, p16 INK4a and NF-κB, contributing to the senescence-associated secretory phenotype (SASP). Downregulation of either Cx43 by CRISPR/Cas9 or Cx43-mediated gap junctional intercellular communication (GJIC) by carbenoxolone treatment triggered rediferentiation of osteoarthritic chondrocytes into a more differentiated state, associated with decreased synthesis of MMPs and proinflammatory factors, and reduced senescence. We have identified causal Cx43-sensitive circuit in chondrocytes that regulates dedifferentiation, redifferentiation and senescence. We propose that chondrocytes undergo chondrocyte-mesenchymal transition where increased Cx43-mediated GJIC during OA facilitates Twist-1 nuclear translocation as a novel mechanism involved in OA progression. These findings support the use of Cx43 as an appropriate therapeutic target to halt OA progression and to promote cartilage regeneration.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T, A Rationale for Novel Therapeutic Approaches

  • Martínez, Alba
  • Sesé, Marta|||0000-0003-1473-4833
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Robichaud, Nathaniel
  • Sonenberg, Nahum
  • Aasen, Trond|||0000-0003-0763-2695
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Phosphorylation of the eukaryotic translation initiation factor eIF4E is associated with malignant progression and poor cancer prognosis. Accordingly, here we have analyzed the association between eIF4E phosphorylation and cellular resistance to oxidative stress, starvation, and DNA-damaging agents in vitro. Using immortalized and cancer cell lines, retroviral expression of a phosphomimetic (S209D) form of eIF4E, but not phospho-dead (S209A) eIF4E or GFP control, significantly increased cellular resistance to stress induced by DNA-damaging agents (cisplatin), starvation (glucose+glutamine withdrawal), and oxidative stress (arsenite). De novo accumulation of eIF4E-containing cytoplasmic bodies colocalizing with the eIF4E-binding protein 4E-T was observed after expression of phosphomimetic S209D, but not S209A or wild-type eIF4E. Increased resistance to cellular stress induced by eIF4E-S209D was lost upon knockdown of endogenous 4E-T or use of an eIF4E-W73A-S209D mutant unable to bind 4E-T. Cancer cells treated with the Mnk1/2 inhibitor CGP57380 to prevent eIF4E phosphorylation and mouse embryonic fibroblasts derived from Mnk1/2 knockout mice were also more sensitive to arsenite and cisplatin treatment. Polysome analysis revealed an 80S peak 2 hours after arsenite treatment in cells overexpressing phosphomimetic eIF4E, indicating translational stalling. Nonetheless, a selective increase was observed in the synthesis of some proteins (cyclin D1, HuR, and Mcl-1). We conclude that phosphorylation of eIF4E confers resistance to various cell stressors and that a direct interaction or regulation of 4E-T by eIF4E is required. Further delineation of this process may identify novel therapeutic avenues for cancer treatment, and these results support the use of modern Mnk1/2 inhibitors in conjunction with standard therapy.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

  • Merino Galán, Leyre
  • Jiménez Urbieta, Haritz
  • Zamarbide, Marta
  • Rodríguez Chinchilla, Tatiana
  • Belloso Iguerategui, Arantzazu
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Aiastui, Ana
  • Doudnikoff, Evelyne.
  • Bézard, Erwan
  • Ouro, Alberto
  • Knafo, Shira
  • Gago, Belén
  • Quiroga Varela, Ana
  • Rodríguez Oroz, María Cruz
Synaptic impairment might precede neuronal degeneration in Parkinson’s disease. However, the intimate mechanisms altering synaptic function by the accumulation of presynaptic α-synuclein in striatal dopaminergic terminals before dopaminergic death occurs, have not been elucidated. Our aim is to unravel the sequence of synaptic functional and structural changes preceding symptomatic dopaminergic cell death. As such, we evaluated the temporal sequence of functional and structural changes at striatal synapses before parkinsonian motor features appear in a rat model of progressive dopaminergic death induced by overexpression of the human mutated A53T α-synuclein in the substantia nigra pars compacta, a protein transported to these synapses. Sequential window acquisition of all theoretical mass spectra proteomics identified deregulated proteins involved first in energy metabolism and later, in vesicle cycling and autophagy. After protein deregulation and when α-synuclein accumulated at striatal synapses, alterations to mitochondrial bioenergetics were observed using a Seahorse XF96 analyser. Sustained dysfunctional mitochondrial bioenergetics was followed by a decrease in the number of dopaminergic terminals, morphological and ultrastructural alterations, and an abnormal accumulation of autophagic/endocytic vesicles inside the remaining dopaminergic fibres was evident by electron microscopy. The total mitochondrial population remained unchanged whereas the number of ultrastructurally damaged mitochondria increases as the pathological process evolved. We also observed ultrastructural signs of plasticity within glutamatergic synapses before the expression of motor abnormalities, such as a reduction in axospinous synapses and an increase in perforated postsynaptic densities. Overall, we found that a synaptic energetic failure and accumulation of dysfunctional organelles occur sequentially at the dopaminergic terminals as the earliest events preceding structural changes and cell death. We also identify key proteins involved in these earliest functional abnormalities that may be modulated and serve as therapeutic targets to counterbalance the degeneration of dopaminergic cells to delay or prevent the development of Parkinson’s disease., This study was funded by the Instituto de Salud Carlos III through the projects PI14/00763 and PI19/01915 (co-funded by ERDF/ESF, ‘Investing in your future’). L.M.-G. held a Predoctoral Research Fellowship from the University of the Basque Country (UPV/EHU). T.R.-C. and A.Q.-V. were funded by CIBERNED. T.R.-C. held a Fundación Jesús de Gangoiti Barrera Foundation grant (Bilbao, Spain). H.J.-U. and A.B.-I. held a Predoctoral Research Fellowship from the Government of the Basque Country. Israel Science Foundation (536/19) and the Spanish Ministry of Science (SAF2016-78071-R) funded the contribution of S.K. and A.O.